Cargando…

Timing the Emergence of Resistance to Anti-HIV Drugs with Large Genetic Barriers

New antiretroviral drugs that offer large genetic barriers to resistance, such as the recently approved inhibitors of HIV-1 protease, tipranavir and darunavir, present promising weapons to avert the failure of current therapies for HIV infection. Optimal treatment strategies with the new drugs, howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arora, Pankhuri, Dixit, Narendra M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643484/ https://www.ncbi.nlm.nih.gov/pubmed/19282958 http://dx.doi.org/10.1371/journal.pcbi.1000305

Ejemplares similares

Emergence of Recombinant Forms of HIV: Dynamics and Scaling
por: Suryavanshi, Gajendra W, et al.
Publicado: (2007)

Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection
por: Saha, Ananya, et al.
Publicado: (2020)

Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19
por: He, Lin, et al.
Publicado: (2023)

HIV Genetic Diversity and Drug Resistance
por: Santos, André F., et al.
Publicado: (2010)

Mutational pathway maps and founder effects define the within-host spectrum of hepatitis C virus mutants resistant to drugs
por: Raja, Rubesh, et al.
Publicado: (2019)

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents
por: Gupta, Vipul, et al.
Publicado: (2018)

Standing Genetic Variation and the Evolution of Drug Resistance in HIV
por: Pennings, Pleuni Simone
Publicado: (2012)

Transmitted HIV-1 is more virulent in heterosexual individuals than men-who-have-sex-with-men
por: James, Ananthu, et al.
Publicado: (2022)

The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients
por: Beerenwinkel, Niko, et al.
Publicado: (2013)

Estimating the Threshold Surface Density of Gp120-CCR5 Complexes Necessary for HIV-1 Envelope-Mediated Cell-Cell Fusion
por: Mulampaka, Shiva Naresh, et al.
Publicado: (2011)

Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India
por: Chauhan, C. K., et al.
Publicado: (2019)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
por: Theys, Kristof, et al.
Publicado: (2010)

HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo
por: Niama, Fabien Roch, et al.
Publicado: (2017)

Modeling Drug Resistance Emergence and Transmission in HIV-1 in the UK
por: Zhukova, Anna, et al.
Publicado: (2023)

Emergence of multi drug resistant nonfermentative Acinetobacter spp in a tertiary care hospital
por: Amol, Shyamkuwar, et al.
Publicado: (2012)

Stochastic Simulations Suggest that HIV-1 Survives Close to Its Error Threshold
por: Tripathi, Kushal, et al.
Publicado: (2012)

Effect of drug dose and timing of treatment on the emergence of drug resistance in vivo in a malaria model
por: Acosta, Mónica M, et al.
Publicado: (2020)

Genetic Variability of HIV-1 for Drug Resistance Assay Development
por: Clutter, Dana S., et al.
Publicado: (2016)

Barriers to Improving Patient Safety in India: Focus Groups with Providers in the Southern State of Kerala
por: Landefeld, John, et al.
Publicado: (2015)

A18 HIV-1 genetic diversity and drug resistance in Haiti
por: Delva, G, et al.
Publicado: (2018)

The transmission of drug-resistant strains of HIV in heterosexual populations based on genetic sequences
por: Jin, Xin, et al.
Publicado: (2021)

Confronting TB/HIV in the era of increasing anti-TB drug resistance
por: Chakaya, Jeremiah, et al.
Publicado: (2008)

Comparative analysis of anti-fogging agents and their combination for protective eyewear in COVID-19 intensive care units
por: Varshney, Toshit, et al.
Publicado: (2021)

The state-of-the-art of emergency contraception with the cutting edge drug
por: Sarkar, Narendra Nath
Publicado: (2011)

A12 Modeling residual HIV replication and the emergence of drug resistance on ART
por: Michael Bale, J, et al.
Publicado: (2019)

HIV-1 Epidemiology, Genetic Diversity, and Primary Drug Resistance in the Tyumen Oblast, Russia
por: Gashnikova, Natalya M., et al.
Publicado: (2016)

Viral Decay Dynamics and Mathematical Modeling of Treatment Response: Evidence of Lower in vivo Fitness of HIV-1 Subtype C
por: Shet, Anita, et al.
Publicado: (2016)

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance
por: Gehre, Florian, et al.
Publicado: (2016)

Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia
por: Hoare, Alexander, et al.
Publicado: (2010)

A mathematical study on the drug resistant virus emergence with HIV/AIDS treatment cases
por: Chang, Hyeygjeon
Publicado: (2021)

Frequency of Drug-Resistant Variants of HIV-1 Coexistent With Wild-Type in Treatment-Naive Patients of India
por: Sachdeva, Naresh, et al.
Publicado: (2005)

Hsp90 Inhibitors and the Reduction of Anti-Cancer Drug Resistance by Non-Genetic and Genetic Mechanisms
por: Lu, Xiangyi, et al.
Publicado: (2012)

Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection
por: Lukoye, Deus, et al.
Publicado: (2011)

Taking Multiple Infections of Cells and Recombination into Account Leads to Small Within-Host Effective-Population-Size Estimates of HIV-1
por: Balagam, Rajesh, et al.
Publicado: (2011)

Emergence of HIV-1 drug resistance mutations in mothers on treatment with a history of prophylaxis in Ghana
por: Martin-Odoom, Alexander, et al.
Publicado: (2018)

Medical barriers to emergency contraception: a cross-sectional survey of doctors in North India
por: Khan, M E, et al.
Publicado: (2014)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
por: Piralla, Antonio, et al.
Publicado: (2011)

HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria
por: Oluniyi, Paul E., et al.
Publicado: (2022)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective
por: Foll, Matthieu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f3louk2bmd94asesnqh860jnfo